2) Adventures in Statistics I: How regulators and journals came to accept and perhaps even embrace adaptive Bayesian clinical trials
Loading...
Media is loading
Description
This lecture was presented on October 26, 2021.
Recorded lecture and slides are available to view and download
The Adventures in Statistics I was organized by Dr. J. Jack Lee and Dr. Yu Shen from the Department of Biostatistics.
References
- Biostatistics Software by Quantitative Research Computing at MD Anderson (Desktop/Cloud)
- Berry DA. Emerging innovations in clinical trial design. Clin Pharmacol Ther. 2016;99(1):82-91.
- Berry DA. The Brave New World of clinical cancer research: Adaptive biomarker-driven trials integrating clinical practice with clinical research. Mol Oncol. 2015;9(5):951-959.
- Berry DA. Bayesian clinical trials. Nat Rev Drug Discov. 2006;5(1):27-36.
- Berry SM, Carlin BP, Lee JJ, and Mueller P. Bayesian Adaptive Methods for Clinical Trials. CRC Press: Boca Raton, FL, 2010.
- Biswas S, Liu DD, Lee JJ, Berry DA. Bayesian clinical trials at the University of Texas MD Anderson Cancer Center. Clin Trials. 2009;6(3):205-16.
- Tidwell RSS, Peng SA, Chen M, Liu DD, Yuan Y, Lee JJ. Bayesian clinical trials at The University of Texas MD Anderson Cancer Center: An update. Clin Trials. 2019;16(6):645-656.
Publication Date
10-26-2021
City
Houston
Keywords
Bayesian; Clinical Trials; Research Design
Recommended Citation
Berry, Donald A. PhD, "2) Adventures in Statistics I: How regulators and journals came to accept and perhaps even embrace adaptive Bayesian clinical trials" (2021). Adventures in Statistics Lecture Series II. 2.
https://openworks.mdanderson.org/biostatistics_adventures/2
